BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9176296)

  • 1. Role of endogenous centrally released NO in cardiovascular adaptation to hypovolemia in WKY and SHR.
    Paczwa P; Budzikowski AS; Szczepańska-Sadowska E
    Am J Physiol; 1997 May; 272(5 Pt 2):H2282-8. PubMed ID: 9176296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of central pressor effect of AVP in SHR and WKY rats by intracranial N(G)-nitro-L-arginine.
    Paczwa P; Budzikowski AS; Szczepańska-Sadowska E
    Brain Res; 1997 Feb; 748(1-2):51-61. PubMed ID: 9067444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central V1 AVP receptors are involved in cardiovascular adaptation to hypovolemia in WKY but not in SHR.
    Budzikowski AS; Paczwa P; Szczepańska-Sadowska E
    Am J Physiol; 1996 Sep; 271(3 Pt 2):H1057-64. PubMed ID: 8853341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of NG-nitro-L-arginine on pressor action of arginine vasopressin in normotensive (WKY) and spontaneously hypertensive (SHR) rats.
    Styś T; Szczepańska-Sadowska E
    J Physiol Pharmacol; 1994 Jun; 45(2):231-40. PubMed ID: 7949233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure responses to substances interfering with nitric oxide formation, cyclooxygenase and converting enzyme activities and vasopressin V1 receptors blockade in conscious spontaneously hypertensive and normotensive rats.
    Januszewicz A; Lapiński M; Styś T; Styś A; Loń S
    Pol J Pharmacol; 1994; 46(3):153-61. PubMed ID: 8000447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous nitric oxide on arterial hemodynamics: a comparison between normotensive and hypertensive rats.
    Chen HI; Hu CT
    Am J Physiol; 1997 Oct; 273(4):H1816-23. PubMed ID: 9362248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centrally produced neuronal nitric oxide in the control of baroreceptor reflex sensitivity and blood pressure in normotensive and spontaneously hypertensive rats.
    Qadri F; Carretero OA; Scicli AG
    Jpn J Pharmacol; 1999 Nov; 81(3):279-85. PubMed ID: 10622216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predisposition of spontaneously hypertensive rats to develop renal injury during nitric oxide synthase inhibition.
    Verhagen AM; Koomans HA; Joles JA
    Eur J Pharmacol; 2001 Jan; 411(1-2):175-180. PubMed ID: 11137873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central ANP attenuates pressor responses to central AVP in WKY and SHR.
    Stepniakowski K; Budzikowski A; Lon S; Szczepanska-Sadowska E
    Brain Res Bull; 1991 Aug; 27(2):247-9. PubMed ID: 1835898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal-induced antihypertensive effect of vasopressin: role of the L-arginine/nitric oxide pathway.
    Talom RT; McNeill JR
    Can J Physiol Pharmacol; 1997 Jul; 75(7):812-7. PubMed ID: 9315348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral blood flow during inhibition of brain nitric oxide synthase activity in normal, hypertensive, and stroke-prone rats.
    Izuta M; Clavier N; Kirsch JR; Traystman RJ
    Stroke; 1995 Jun; 26(6):1079-85. PubMed ID: 7539167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary vascular reactivity of spontaneously hypertensive rats is exacerbated in response to the central administration of exogenous nitric oxide.
    Schwenke DO; Pearson JT; Tsuchimochi H; Kangawa K; Shirai M
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):88-94. PubMed ID: 17201741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centrally applied vasopressin intensifies hypotension and bradycardia after hemorrhage in shr rats.
    Dobruch J; Paczwa P; Loń S; Szczepańska-Sadowska E
    J Physiol Pharmacol; 2002 Jun; 53(2):295-8. PubMed ID: 12120904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased hypotensive responsiveness to nitric oxide donor S-nitroso N-acetyl-DL-penicillamine (SNAP) in spontaneously hypertensive (SHR) rats.
    Styś T; Styś A; Paczwa P; Szczepańska-Sadowska E; Lipkowski AW
    J Physiol Pharmacol; 1998 Mar; 49(1):37-49. PubMed ID: 9594409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 1,1-dimethylguanidine administration on blood pressure, heart rate and renal sympathetic nerve activity in normotensive and spontaneously hypertensive rats.
    Zhang W; Pettersson A; Thorén P; Hedner T
    Acta Physiol Scand; 1997 Jan; 159(1):1-6. PubMed ID: 9124065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central cardiovascular effects of AVP and ANP in normotensive and spontaneously hypertensive rats.
    Stepniakowski K; Budzikowski A; Loń S; Szczepańska-Sadowska E
    J Auton Nerv Syst; 1994 Apr; 47(1-2):33-43. PubMed ID: 8188982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NO dependency of RBF and autoregulation in the spontaneously hypertensive rat.
    Racasan S; Joles JA; Boer P; Koomans HA; Braam B
    Am J Physiol Renal Physiol; 2003 Jul; 285(1):F105-12. PubMed ID: 12631552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central cardiovascular effects of baclofen in spontaneously hypertensive rats.
    Singh R; Ticku MK
    Life Sci; 1987 Mar; 40(10):1017-26. PubMed ID: 3029526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrovascular effects of nitric oxide manipulation in spontaneously hypertensive rats.
    Fouyas IP; Kelly PA; Ritchie IM; Whittle IR
    Br J Pharmacol; 1997 May; 121(1):49-56. PubMed ID: 9146886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired effect of nitric oxide synthesis inhibition on tubuloglomerular feedback in hypertensive rats.
    Thorup C; Persson AE
    Am J Physiol; 1996 Aug; 271(2 Pt 2):F246-52. PubMed ID: 8770154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.